Ameriprise
BNTX icon

Ameriprise’s BioNTech BNTX Stock Holding History

Ameriprise’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.31M Buy
89,315
+64,784
+264% +$6.1M ﹤0.01% 2182
2026
Q1 		$2.18M Sell
24,531
-3,942
-14% -$405K ﹤0.01% 2911
2025
Q4 		$2.71M Sell
28,473
-321
-1% -$32.3K ﹤0.01% 2837
2025
Q3 		$2.84M Sell
28,794
-21
-0.1% -$2.25K ﹤0.01% 2799
2025
Q2 		$3.07M Buy
28,815
+289
+1% +$29.2K ﹤0.01% 2702
2025
Q1 		$2.6M Buy
28,526
+1,285
+5% +$144K ﹤0.01% 2758
2024
Q4 		$3.1M Sell
27,241
-1,489
-5% -$170K ﹤0.01% 2676
2024
Q3 		$3.41M Sell
28,730
-16,755
-37% -$1.54M ﹤0.01% 2615
2024
Q2 		$3.66M Buy
45,485
+117
+0.3% +$10.7K ﹤0.01% 2533
2024
Q1 		$4.19M Buy
45,368
+1,959
+5% +$188K ﹤0.01% 2469
2023
Q4 		$4.58M Sell
43,409
-4,171
-9% -$420K ﹤0.01% 2409
2023
Q3 		$5.17M Sell
47,580
-1,367
-3% -$151K ﹤0.01% 2260
2023
Q2 		$5.28M Sell
48,947
-142
-0.3% -$16K ﹤0.01% 2308
2023
Q1 		$6.11M Buy
49,089
+5,371
+12% +$737K ﹤0.01% 2177
2022
Q4 		$6.57M Buy
43,718
+14,814
+51% +$2.28M ﹤0.01% 2091
2022
Q3 		$3.9M Sell
28,904
-3,589
-11% -$549K ﹤0.01% 2396
2022
Q2 		$4.84M Sell
32,493
-345
-1% -$52.7K ﹤0.01% 2308
2022
Q1 		$5.6M Buy
32,838
+10,649
+48% +$1.79M ﹤0.01% 2348
2021
Q4 		$5.72M Buy
22,189
+15,236
+219% +$4.17M ﹤0.01% 2377
2021
Q3 		$1.68M Buy
6,953
+4,448
+178% +$1.41M ﹤0.01% 2939
2021
Q2 		$561K Sell
2,505
-311,578
-99% -$58.8M ﹤0.01% 3412
2021
Q1 		$34.3M Sell
314,083
-103,057
-25% -$10.9M 0.01% 961
2020
Q4 		$34M Sell
417,140
-225,972
-35% -$22.2M 0.01% 923
2020
Q3 		$44.5M Buy
+643,112
New +$46.1M 0.02% 688

Other funds holding BNTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $22.1B AUM 6.81% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
GP
GSK plc London $602M AUM

Ameriprise's BNTX Position: Q2 2026 in Review

Ameriprise increased its BioNTech (BNTX) stake by 264% in Q2 2026, buying an estimated $6.1M and bringing the position to 89,315 shares worth $8.31M. The position accounts for ﹤0.01% of the portfolio, ranked #2182.

Ameriprise first reported a position in BNTX in Q3 2020 and has held it in 24 quarters since. The position peaked at $44.5M in Q3 2020. 282 funds tracked by Wall St. Rank hold BNTX as of Q2 2026.

  • Ameriprise held 89,315 shares of BioNTech worth $8.31M as of Q2 2026.
  • Ameriprise bought 64,784 BioNTech shares in Q2 2026, an estimated $6.1M.
  • BioNTech made up ﹤0.01% of Ameriprise's portfolio in Q2 2026, its #2182 holding.
  • Ameriprise first reported a position in BioNTech in Q3 2020 and has held it in 24 quarters since.
  • Ameriprise's BioNTech position peaked at $44.5M in Q3 2020.
  • 282 funds tracked by Wall St. Rank held BioNTech as of Q2 2026.

Based on Ameriprise's 13F filing for Q2 2026, filed 14 Aug 2026.